NHGRI NIH Earmarks $38M for Consortium Studying Polygenic Risk Scores in Diverse Populations The consortium aims to develop and evaluate methods for calculating polygenic risk scores for specific diseases, particularly for people of different ancestries. Telomere-To-Telomere Team Assembles Complete Human Genome En Route to Reference Pangenome Premium The project leaders hope that T2T-CHM13 will be used as a new linear reference genome while they are generating phased genomes for the Human Pangenome Reference Consortium. Blood Cancer Genetic Risk Loci Found in Retriever Dogs Using a genome-wide association study and multiomic follow up, investigators tracked down genes involved in histiocytic sarcoma in flat-coated retrievers. Study Reveals African Americans' Perspectives on Genomic Research Participation A new study found that African-American participants in genomic research prefer broad and welcoming engagement approaches and nuanced discussions. Invitae to Provide Genetic Testing Within eMERGE Population Screening Study As a new clinical affiliate, Invitae will test up to 25,000 patients in a study exploring the role of genetics in cancer, heart disease, and other conditions. Mar 29, 2021 Armonica Technologies Wins $349K SBIR Grant From NHGRI Mar 5, 2021 Fauna Bio Gets $373K NIH Grant to Study Animal Genomes for Potential Drug Targets Mar 3, 2021 Human Pangenome Reference Consortium Releases Data From 30 Genomes Jan 7, 2021 NHGRI Sets Plan to Diversify Genomics Workforce Dec 23, 2020 AnVIL Platform Makes Popular NHGRI GTEx Database Free to Download Premium Nov 5, 2020 Jackson Laboratory Wins $3.4M NHGRI Grant to Study Workplace Genomic Testing Oct 28, 2020 Q&A: NHGRI's Eric Green on Advancements and Ongoing Challenges in Genomics Premium Oct 28, 2020 NHGRI Lays Out Strategic Vision, Future Priorities for Genomics Research Oct 28, 2020 'Genotype-First' Study Leads to Blood Cell Mutations Underlying Severe Autoinflammatory Disease Premium Oct 6, 2020 Startup Coral Genomics Wins $2M SBIR Grant From NIH Aug 24, 2020 Kromatid Wins NHGRI Grant to Develop Single-Cell Structural Genomics Tech for Disease Research Jul 29, 2020 ENCODE Phase Three Offers New Insights Into Genomic Regulatory Regions, Organization Jul 22, 2020 Risk-Assessment Phase of eMERGE Looks to Diversify Polygenic Risk Scoring Premium Jul 14, 2020 Telomere-to-Telomere Team Shares Complete X Chromosome Assembly Apr 16, 2020 NHGRI Publishes Draft of 2020 Strategic Roadmap Feb 28, 2020 NHGRI Precision Health Research Program Using Reverse Phenotyping to Better Understand Genomics Premium Feb 14, 2020 NHGRI Creates New Precision Health Research Program Feb 10, 2020 President Trump Calls for 8 Percent Cut to NIH Budget Feb 4, 2020 NHGRI to Award $14.3M in Funding for Mendelian Genomics Centers Oct 24, 2019 NHGRI Plans $33.8M in Funding for Polygenic Risk Score Consortium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.